Literature DB >> 32928083

A Potential MRI Agent and an Anticancer Drug Encapsulated within CPMV Virus-Like Particles.

Alaa A A Aljabali1, Lorca Alzoubi2, Yassmen Hamzat1, Alaa Alqudah1, Mohammad A Obeid1, Mazhar S Al Zoubi3, Raed M Ennab4, Walhan Alshaer5, Khaled Albatayneh6, Bahaa Al-Trad6, Dana A Alqudah5, Dinesh Kumar Chellappan7, Gaurav Gupta8, Murtaza M Tambuwala9, Dua Kamal10, David J Evans11.   

Abstract

BACKGROUND: Virus nanoparticles have been extensively studied over the past decades for theranostics applications. Viruses are well-characterized, naturally occurring nanoparticles that can be produced in high quantity with a high degree of similarity in both structure and composition.
OBJECTIVES: The plant virus Cowpea Mosaic Virus (CPMV) has been innovatively used as a nanoscaffold. Utilization of the internal cavity of empty Virus-Like Particles (VLPs) for the inclusion of therapeutics within the capsid has opened many opportunities in drug delivery and imaging applications.
METHODS: The encapsidation of magnetic materials and anticancer drugs was achieved. SuperscriptCPMV denotes molecules attached to the external surface of CPMV and CPMVSubscript denotes molecules within the interior of the capsid.
RESULTS: Here, the generation of novel VLPs incorporating iron-platinum nanoparticles TCPMVFePt and cisplatin (Cis) (TCPMVCis) is reported. TCPMVCis exhibited a cytotoxic IC50 of TCPMVCis on both A549 and MDA-MB-231 cell lines of 1.8 μM and 3.9 μM, respectively after 72 hours of incubation. The TCPMVFePt were prepared as potential MRI contrast agents.
CONCLUSION: Cisplatin loaded VLP (TCPMVCis) is shown to enhance cisplatin cytotoxicity in cancer cell lines with its potency increased by 2.3-folds. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Virus-like particles; bioconjugation; cisplatin; drug delivery; nanomedicine.; viruses

Mesh:

Substances:

Year:  2021        PMID: 32928083     DOI: 10.2174/1386207323666200914110012

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  2 in total

Review 1.  SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments.

Authors:  Adedapo Adesokan; Mohammad A Obeid; Aisha F Lawal
Journal:  Ther Deliv       Date:  2022-02-23

Review 2.  SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants.

Authors:  Almu'atasim Khamees; Jamal Bani-Issa; Mazhar Salim Al Zoubi; Taqwa Qasem; Manal Issam AbuAlArjah; Sura Ahmad Alawadin; Khayry Al-Shami; Farah E Hussein; Emad Hussein; Ibrahim H Bashayreh; Murtaza M Tambuwala; Mohannad Al-Saghir; Christopher T Cornelison
Journal:  Pathogens       Date:  2022-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.